Byotrol Share Discussion Threads

[lancasterbomber] 27/1/2021 12:22

From Unilever board
I saw that there is again rumour of Unilever buying the small AIM company Byotrol (BYOT). Yes when I saw that I bought in yesterday on a dip. On my research into BYOT I found out they had a 24 hour product for defence against bacteria / virus, had a few ex employees from Unilever in the management team and no debt. They had a government grant to look into covid long term daily defence on surfaces and could be going into the NHS / airplanes and public transport. Worth a look...

[onehanded] 27/1/2021 11:19

BYOT will bring forward a 24 hour product for defence against bacteria / virus on hard surfaces, the government grant was to look into covid long term daily defence on surfaces and could be going into the NHS / airplanes and public transport.

Byotrol plc (BYOT.L), is a specialist infection prevention and control company, operating globally in the Healthcare, Industrial, Food and Consumer sectors, providing low toxicity products with a broad-based and targeted efficacy across all microbial classes; bacteria, viruses (including coronavirus), fungi, moulds, mycobacteria and algae.

From RNS in Dec

-Completion of licensing-out of Byotrol24 surface sanitizer to Integrated Resources Inc. in the US -expected to provide significant returns to Byotrol for minimal ongoing US costs
-Solvay has globally launched Actizone 24 hour surface sanitizer, referring to it as a "blockbuster technology"
-Grant of GBP350,000 secured for seaweed research programme

Debt 0 - please note

[football] 27/1/2021 10:32

Cars & COVID-19
From family road trips to ride-sharing, cars can be dirty, germy places—COVID-19 notwithstanding. Brands are taking action to address concerns and unmet needs.

Cars & COVID-19
Christine Esposito, Managing Editor
01.26.21

[1gw] 27/1/2021 08:43

The non-current trade receivables are the discounted values of the future (more than 12 months out) guaranteed payments (adjusted for ongoing performance obligations) due under the licence agreements. So at 31st March, the total was £714k and this I think must relate to the Tristel licence agreement concluded in FY20, while the £1.1m reported at 30th September will add in amounts for the IRI and SC Johnson deals concluded in 1H FY21, net of any of the £714k that had moved to current receivables by 30th September.

[onehanded] 27/1/2021 08:33

Can buy at 6.8 this am

From simply wall st - market - so 50% below fair value!!

Below Fair Value: BYOT (£0.07) is trading below our estimate of fair value (£0.14)

'I like to take a look at earnings before interest and (EBIT) tax margins, as well as revenue growth, to get another take on the quality of the company's growth. Byotrol shareholders can take confidence from the fact that EBIT margins are up from 8.9% to 12%, and revenue is growing. That's great to see, on both counts.'

Short Term Liabilities: BYOT's short term assets (£5.0M) exceed its short term liabilities (£1.7M).
Long Term Liabilities: BYOT's short term assets (£5.0M) exceed its long term liabilities (£387.0K).

[the ghost who walks] 27/1/2021 08:31

Was look8ng at the balance sheet, we had about 5mln current assets and 1.3mkn current liabilities. Current assets included about 1mln of stock.We seem to be in a very strong financial position which, I think, will only improve in 2h further.In addition we had about 1mln of trade rece8vables that are non current. Not sure how to interpret that.

[football] 26/1/2021 20:51

Dr. Armand Dorian Recommends Byotrol24
Byotrol24 Sanitizes Surfaces for 24-hours

[football] 26/1/2021 20:45

Byotrol

If like us, you've noticed the lack of support for alternative biocidal technologies against SARS-CoV-2 (which causes COVID-19) you'll be pleased to see this report in
@jhieditor








Alcohol-free hand sanitizer and other quaternary ammonium disinfectants quickly and effectively inactivate SARS-CoV-2

[football] 26/1/2021 20:42

We are honored by
@Henkel
's recognition of our contribution to #Innovation and #sustainability in the home care field:
Soap Runner up in the 2020 Innovation Contributor category for Actizone™.
Universal recycling symbol Runner up in Sustainability for RhodasurfRegistered sign 6 NAT








Long-time partner Henkel recognizes Solvay's ActizoneTM, a 24-hour antimicrobial cleaning technology, and Rhodasurf®️ 6 NAT, a bio-based surfactant.
Brussels, January 26, 2021 - 8:00

[onehanded] 26/1/2021 12:46

From simply wall st - market - so 50% below fair value!!

Below Fair Value: BYOT (£0.07) is trading below our estimate of fair value (£0.14)

'I like to take a look at earnings before interest and (EBIT) tax margins, as well as revenue growth, to get another take on the quality of the company's growth. Byotrol shareholders can take confidence from the fact that EBIT margins are up from 8.9% to 12%, and revenue is growing. That's great to see, on both counts.'

Short Term Liabilities: BYOT's short term assets (£5.0M) exceed its short term liabilities (£1.7M).
Long Term Liabilities: BYOT's short term assets (£5.0M) exceed its long term liabilities (£387.0K).

[onehanded] 26/1/2021 12:33

think as debt free company and increase revenue volume this has to test 10p again.

[riddlerone] 26/1/2021 12:31

Here's an old (October)but very relevant article thats similar to Solvay/Henkel

Microban 24 wasn’t expected to be a major product before Procter & Gamble Co. introduced it in February. Then came Covid-19. The sanitizing spray -- P&G’s answer to Lysol and Clorox -- is in demand with the coronavirus pandemic causing a rush for household cleaning supplies. On Monday, Microban got perhaps its biggest vote of confidence yet, as the packaged-goods giant said the spray was approved by the U.S. Environmental Protection Agency as effective in killing the virus that causes Covid-19.

[1gw] 26/1/2021 11:28

I'd expect to see a hard surface disinfection product though...

[riddlerone] 26/1/2021 11:07

Looks to be positioned the same as Fairy liquid in the Uk

Pril, first launched in 1951, remains to this day the number 1 hand dishwashing liquid in Germany. With a footprint that is now global, Pril offers consumers the best in class solution to tough stains ranging from grease to starch and so much more.

[loafofbread] 26/1/2021 10:06

Managed to pick up a line of stock at 6.8p.

My gain I hope.

[tradertrev] 26/1/2021 09:49

If we have Henkel on board launching and selling Actizone-based products that is a game-changer.
I've always wondered why Unilever wasn't interested in Byotrol despite a number of senior ex-Unilever R&D personnel working here. I suspect this is due to their vested interest in "one-hit" bleach-based cleaners (e.g. Domestos) that stop killing bugs as soon as they dry. They have more to lose if these 24-hour surface cleaners take off (just like Reckitt-Benckiser with Dettox) and feel they can sustain their position against a minnow like Byotrol with their blockbuster marketing and advertising resources.
However, if serious global players like Solvay and hopefully now Henkel are promoting these products there will come a tipping point when all FMCG companies will need a 24-hour cleaner, because consumers will finally have got the message about the advantages.
Also interesting that Henkel have a big position in "one-hit" cleaners - Jeyes Fluid - so perhaps they have seen the way forward quicker than their rivals?
It will be fascinating to see how this plays out.

[1gw] 26/1/2021 09:39

This one sounds possible:

"The new Pril variant removes 99.9 percent of the bacteria from dishes and cutlery and also provides up to 24 hours of protection against bacteria on the sponge1."

[riddlerone] 26/1/2021 09:10

It does sound like its already happened 1gw but as you said no evidence yet.Just in case anyone else wants to know the size of Henkel

[1gw] 26/1/2021 09:01

That's great to see riddlerone. I have been regularly searching for news of Henkel's Actizone products, since Solvay put Henkel on that slide alongside Wings and talked about first sales to Germany. I haven't yet found a product or a launch from Henkel though. Has anyone else? That article suggests ("our collaboration with Henkel") that they've been actively involved in the product's development so I would have thought they would already be marketing a 24 hour disinfectant.

[1gw] 25/1/2021 15:16

I can't argue with that.

[the ghost who walks] 25/1/2021 15:07

If they achieve that then I do think the mcap will be substantial

[1gw] 25/1/2021 14:21

On that, I think finnCap's approach is reasonable ahead of getting an actual royalty curve to extrapolate.

FinnCap estimated, for the Solvay deal:
- the size of the addressable market (they did it ex-US)
- the share that Solvay could reasonably target
- the build-up profile in the first few years to get to that share
- the % royalty due to byotrol

And they came up with £5m+ (ex-US) income to byotrol by year 3-5 on that basis.

But clearly the number is very sensitive to the assumptions on addressable market, market share and royalty %.

I don't think we even know if the Solvay commission is payable quarterly or annually. But on IRI we know the royalty is quarterly and so royalty ought to start showing up in the accounts (at least cashflow and hopefully income if it exceeds the guaranteed minimum already booked) in the 1H interims, if not in the upcoming FY21 full-year accounts.

[the ghost who walks] 25/1/2021 12:30

Good point, think you are right.Now the question is how to size it for us